CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-25 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −21,360 | $32.47 | $694K | 265,922 |
| 2021-06-25 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +28,640 | $19.47 | $558K | 294,562 |
| 2021-06-25 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −28,640 | $31.97 | $916K | 265,922 |
| 2021-06-25 | LANCHBURY JERRY S Chief Scientific Officer | Sale | −33,372 | $31.61 | $1.1M | 232,550 |
| 2021-06-25 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −21,360 | 47,280 | ||
| 2021-06-25 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −28,640 | 18,640 | ||
| 2021-06-17 | SPIEGELMAN DANIEL K Director | Sale | −3,139 | $30.52 | $96K | 23,129 |
| 2021-06-03 | Kumar Rashmi Director | Grant or award | +12,848 | 36,771 | ||
| 2021-06-03 | Newcomer Lee Nisley Director | Grant or award | +12,848 | 40,424 | ||
| 2021-06-03 | DREISMANN HEINRICH Director | Grant or award | +12,848 | 83,527 | ||
| 2021-06-03 | LANGER DENNIS Director | Grant or award | +12,848 | 89,527 | ||
| 2021-06-03 | SPIEGELMAN DANIEL K Director | Grant or award | +12,848 | 26,268 | ||
| 2021-06-03 | Skovronsky Daniel Director | Grant or award | +12,848 | 37,889 | ||
| 2021-06-03 | Reitan Colleen F Director | Grant or award | +12,848 | 40,424 | ||
| 2021-06-03 | Phanstiel S. Louise Director | Grant or award | +12,848 | 79,527 | ||
| 2021-05-28 | Haas Kevin Richard Chief Technology Officer | Grant or award | +344 | $15.86 | $5K | 56,113 |
| 2021-05-28 | Hart Jayne B. Chief People Officer | Grant or award | +1,082 | $15.86 | $17K | 81,210 |
| 2021-05-28 | SPIEGELMAN DANIEL K Director | Sale | −7,142 | $28.99 | $207K | 13,420 |
| 2021-05-27 | SPIEGELMAN DANIEL K Director | Returned to the company | −15,889 | 20,562 | ||
| 2021-05-04 | LANCHBURY JERRY S Chief Scientific Officer | Exercise or conversion | +19,360 | $19.47 | $377K | 285,282 |
Page 27 of 35 · 689 trades